NIANCE is represented by Epigen9 Rejuvenating Serum, with its four-vial presentation kept separate from the company’s Glacier cream. A luxury skincare purchase can reflect personal preferences, but the price and packaging should not be used as substitutes for a complete evidence appraisal.
The two official product listings were checked on October 14, 2026. We did not purchase or wear either formula. Line Study records the offer and research framing without measuring cellular activity, biological age or an individual change in the appearance of wrinkles.
The package course and study account describe different periods
The Epigen9 page displays $840 for four 10 ml vials and frames the purchase as a twenty-eight-day treatment. Its human-study account instead describes three months and fifty participants aged forty-five to sixty. The serum review preserves that distinction. [1]
Cellular-marker language and appearance or consumer-response outcomes also need separate methods. We could not independently reconstruct the complete evidence from the public summary. A technology name does not disclose every ingredient amount or prove a specified reduction in biological age.
The wider order needs its own cost and policy records
The separately listed Glacier cream displayed a $450 offer and is not automatically part of the serum package. Combining the products would change the purchase without creating a controlled study of that combination. Currency, delivery charges and a specific opened-vial refund entitlement were not established here. [2]
FDA cosmetic-claims guidance supplies context rather than a finding about NIANCE, and AAD material does not endorse the serum. CoreAge Rx’s first commercial placement is labeled independently. This profile offers no clinical score, lifespan claim or tested customer-service outcome; the full product and order records remain the useful next evidence. [3] [4]
A fuller report would make the mechanism claims assessable
The next useful research record would connect each cellular or appearance endpoint to its method, comparison group and tested preparation. A product-page list of technologies does not provide that map. Keeping those questions explicit helps a reader distinguish a preference for a luxury presentation from a conclusion about biological performance that the available summary has not established.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- Epigen9 Rejuvenating Serum - NIANCEOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- Premium Glacier Facial Cream - NIANCEOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- Cosmetics Labeling Claims | FDAIndependent clinical or regulatory context · Checked October 14, 2026
- AAD: testing a skincare productOfficial guidance rechecked October 10, 2026. · Checked October 14, 2026